Burke W. Whitman

Burke W. Whitman is a declared insider at 2 companies (senior executive); the most frequent names are Amicus Therapeutics, Inc. and Omega Healthcare Investors Inc. In total, 53 filings cover trades dated from 31 October 2018 to 27 April 2026.

The open-market record is one-sided, with 36 purchases worth €648k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 16 share grants.

The median purchase comes to €15k. Clusters matter here: 1 out of 36 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. For 23 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 48% of cases, with a median move of -0.9%. They describe history only and say nothing certain about the share price ahead.

On 27 April 2026 came the latest disclosure, a transaction for €1.5M in Amicus Therapeutics, Inc. The last insider purchase was made public on 3 November 2021, 1,816 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.